Search by Drug Name or NDC
NDC 62135-0220-60 Chlordiazepoxide Hydrochloride 5 mg/1 Details
Chlordiazepoxide Hydrochloride 5 mg/1
Chlordiazepoxide Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is CHLORDIAZEPOXIDE HYDROCHLORIDE.
MedlinePlus Drug Summary
Chlordiazepoxide is used to relieve anxiety and to control agitation caused by alcohol withdrawal. Chlordiazepoxide is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.
Related Packages: 62135-0220-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Chlordiazepoxide
Product Information
| NDC | 62135-0220 |
|---|---|
| Product ID | 62135-220_06fce480-76fc-a204-e063-6394a90a3bbc |
| Associated GPIs | 57100020100105 |
| GCN Sequence Number | 003736 |
| GCN Sequence Number Description | chlordiazepoxide HCl CAPSULE 5 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14033 |
| HICL Sequence Number | 001610 |
| HICL Sequence Number Description | CHLORDIAZEPOXIDE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Chlordiazepoxide Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Chlordiazepoxide Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE |
| Labeler Name | Chartwell RX, LLC |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA084678 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0220-60 (62135022060)
| NDC Package Code | 62135-220-60 |
|---|---|
| Billing NDC | 62135022060 |
| Package | 60 CAPSULE in 1 BOTTLE (62135-220-60) |
| Marketing Start Date | 2022-04-18 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.18428 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | CHLORDIAZEPOXIDE 5 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis